KBI BIOPHARMA
Live / Registered — Registered and renewed (as of 16 Dec 2022)
What this means for you
Registered since 28 May 2013. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 28 May 2023).
Record
- Serial number
- 85566501
- Registration number
- 4340914
- Mark type
- Stylized text
- Filed
- 12 Mar 2012
- Published for opposition
- 12 Mar 2013
- Registered
- 28 May 2013
- Next maintenance due
- 28 May 2023
- Attorney of record
- F. Michael Sajovec
Goods and services
- Class 040 — Treatment of materials: contract manufacturing in the field of biopharmaceuticals
- Class 042 — Scientific and technological services: contract biopharmaceutical drug development services
Owner
- KBI Biopharma, Inc., Durham, NC, US
- KBI Biopharma, Inc., Durham, NC, US
- KBI Biopharma, Inc., Durham, NC, US
Prosecution history
- 16 Dec 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 16 Dec 2022 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 16 Dec 2022 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 15 Dec 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 01 Jun 2022 — TEAS SECTION 8 & 9 RECEIVED
- 28 May 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 06 Jul 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 06 Jul 2019 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 06 Jul 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 28 May 2019 — TEAS SECTION 8 & 15 RECEIVED
- 28 May 2018 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 23 Mar 2016 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 28 May 2013 — REGISTERED-PRINCIPAL REGISTER
- 12 Mar 2013 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Mar 2013 — PUBLISHED FOR OPPOSITION